ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Crown Bioscience, Inc.
We are seeking an outstanding scientist or senior scientist with a solid background in pharmacology and pharmacokinetics to serve as the DMPK project leader. The role involves evaluating the pharmacokinetic features of various molecular types and collaborating closely with cross-functional teams to optimize drug candidates.
Headquarters
San Diego, California, United States
Company Size
1001-5000 employees
Founded
2006
N/A
NaturePreclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Nov 21, 2023
NatureNarazaciclib, a novel multi-kinase inhibitor with potent activity against CSF1R, FLT3 and CDK6, shows strong anti-AML activity in defined preclinical models
Apr 19, 2024
NatureComparison of Continuous Glucose Monitoring between Dexcom G4 Platinum and HD-XG Systems in Nonhuman Primates ( Macaca Fascicularis
Aug 29, 2017
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Crown Bioscience, Inc..
Crown Bioscience, Inc. didn’t post a salary, so this is our estimate from similar listings.
9% above the average for this role